drugset / Trial / NCT01418755
Study of Platelet-rich Plasma in Treating Patients With Tibiofemoral Cartilage Degeneration
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Recently an articular cartilage repair has been given much attention in the orthopaedic field. Cartilage regeneration capacity is very limited. Optimal approach seems to be a delivery of natural growth factors. Autologous platelet-rich plasma (PRP) contains proliferative and chemoattractant growth factors. The objective of the present study was to determine if PRP can increase tibiofemoral cartilage regeneration and improve knee function.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-11
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | — | — |